ACOG (Alpha Cognition) ROE % Adjusted to Book Value: -20.76% (As of Mar. 2026)


ACOG Alpha Cognition Inc ACOG
32 GF Score
Price $6.59
! 3 Warning Signs
View Full Analysis

What is Alpha Cognition ROE % Adjusted to Book Value?

Alpha Cognition ACOG +0.08% 32 ROE % Adjusted to Book Value is -20.76% as of Mar. 2026. GuruFocus rates ACOG with a GF Score™ of 32/100. The stock has 3 warning signs investors should review.

Alpha Cognition's ROE % for the quarter that ended in Mar. 2026 was -43.19%. Alpha Cognition's PB Ratio for the quarter that ended in Mar. 2026 was 2.08. Alpha Cognition's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -20.76%.

Alpha Cognition ROE % Adjusted to Book Value Related Terms

Alpha Cognition ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Alpha Cognition's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpha Cognition ROE % Adjusted to Book Value Chart

Alpha Cognition Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial -58.32 0.00 0.00 -35.69 -18.00

Alpha Cognition Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.68 -24.61 -5.13 -25.16 -20.76

ACOG vs GNLX, VTVT, CRDF: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, Alpha Cognition's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alpha Cognition ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alpha Cognition's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Alpha Cognition's ROE % Adjusted to Book Value falls into.


ACOG
32GF Score
Alpha Cognition Inc ACOG
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpha Cognition ROE % Adjusted to Book Value Calculation

Alpha Cognition's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-40.68% / 2.26
=-18.00%

Alpha Cognition's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-43.19% / 2.08
=-20.76%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -20.76% mean?
Alpha Cognition (ACOG) has a ROE % Adjusted to Book Value of -20.76% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Alpha Cognition and its competitors.
Is Alpha Cognition's ROE % Adjusted to Book Value too high?
Alpha Cognition's current ROE % Adjusted to Book Value is -20.76%. Overall, Alpha Cognition has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Alpha Cognition's ROE % Adjusted to Book Value compare to GNLX and VTVT?
Alpha Cognition's ROE % Adjusted to Book Value of -20.76% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Alpha Cognition and its competitors. Alpha Cognition's current ROE % Adjusted to Book Value is -20.76%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha Cognition stock overvalued right now?
Alpha Cognition (ACOG) has a current ROE % Adjusted to Book Value of -20.76%. The current ROE % Adjusted to Book Value is -20.76%. Alpha Cognition's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Alpha Cognition (ACOG), the current ROE % Adjusted to Book Value is -20.76% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alpha Cognition Business Description

Other Exchanges 7N70:Germany
Address 1200 - 750 West Pender Street, Vancouver, BC, CAN, V6C 2T8
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
32GF Score

Get the complete analysis for ACOG

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.59
Price